» Articles » PMID: 20060245

Exposure to Psychoactive Substances in Women Who Request Voluntary Termination of Pregnancy Assessed by Serum and Hair Testing

Overview
Specialty Forensic Sciences
Date 2010 Jan 12
PMID 20060245
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Drug abuse is a worldwide phenomenon with significant health and socioeconomic impact and it is of particular concern in women of reproductive age and in pregnant women. We aimed to investigate the prevalence of drug use by serum and hair testing in a cohort of pregnant women at 12th week gestation who decided voluntarily to interrupt their pregnancy and to investigate the relationship between drug exposure and induced abortions (IA), repeated IA and contraception. The study was conducted in an obstetrics clinic authorised to perform IA in Murcia, Spain during an 18 months period (2007-2009). Apart from serum and/or hair testing, the 142 women enrolled in the study completed a detailed questionnaire regarding drug, alcohol and tobacco use in the previous 3 months. Serum and hair samples were analyzed by gas chromatography mass spectrometry assays. Hair and serum samples showed a 30% overall positivity to drugs of abuse. Of these samples, 20.4, 14.1, 4.2 and 1.4% were positive for cannabinoids, cocaine, opiates, and MDMA, respectively, with polydrug use in 5.6% cases. In this cohort, a positive association was found between drug use and repeated IA. The results highlight the need for promoting pregnancy planning for young women in general, especially when consuming psychoactive substances as well as promote safe and accessible contraception in women of reproductive age. In women requesting IA, specific drug abuse counselling should be implemented.

Citing Articles

Hair Testing for Classic Drugs of Abuse to Monitor Cocaine Use Disorder in Patients Following Transcranial Magnetic Stimulation Protocol Treatment.

Rotolo M, Pacifici R, Pellegrini M, Cardullo S, Gomez Perez L, Cuppone D Biology (Basel). 2021; 10(5).

PMID: 34062953 PMC: 8148010. DOI: 10.3390/biology10050403.


Drowning our sorrows: clinical and ethical considerations of termination in alcohol-affected pregnancy.

Martin R, Bruxner G, Ng G, Brewster C, Kothari A BMC Pregnancy Childbirth. 2020; 20(1):356.

PMID: 32522252 PMC: 7288674. DOI: 10.1186/s12884-020-03012-9.


Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review.

Roncero C, Valriberas-Herrero I, Mezzatesta-Gava M, Villegas J, Aguilar L, Grau-Lopez L Reprod Health. 2020; 17(1):25.

PMID: 32066469 PMC: 7027300. DOI: 10.1186/s12978-020-0880-9.


Illicit substance use in pregnancy - a review.

Scott K, Lust K Obstet Med. 2016; 3(3):94-100.

PMID: 27579069 PMC: 4989592. DOI: 10.1258/om.2010.100014.


Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort.

Joya X, Gomez-Culebras M, Callejon A, Friguls B, Puig C, Ortigosa S BMC Pregnancy Childbirth. 2012; 12:2.

PMID: 22230295 PMC: 3277455. DOI: 10.1186/1471-2393-12-2.